Onconetix
Business Services · Ohio, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
201 E 5th St Ste 190, Cincinnati, Ohio, ...Phone Number
(513) 620-4101Website
www.onconetix.comRevenue
<$5 MillionStock Symbol
ONCOIndustry
About Onconetix
Onconetix Org Chart
Is Onconetix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Onconetix
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Onconetix has new funding data
Website visits: Recent activity has been detected on your website
Check out if Onconetix is spiking on competitors!
Earning: See what the market has to say on Onconetix recently announced quarterly report
Check if Onconetix has recently received funding, and reach out quickly before it becomes old news!
Onconetix, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Onconetix launches new products
Click to see if Onconetix had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Onconetix as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Onconetix is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Onconetix is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Onconetix.
Onconetix financials insights
Gather financial insights about Onconetix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series C
$2M
Private Equity
$13M
Most Recent Scoops
Onconetix News & Media
Onconetix Reports Q1 2026 Progress at Proteomedix AG, Including Two New Peer-Reviewed Publications and Initiation of U.S. Validation Study
New Clinical Data Reinforce Proclarix® Performance in Reducing Overdiagnosis and Unnecessary Biopsies; Multi-Center PRIME Study Initiated in Collaboration with Labcorp; European Commercial Expansion AdvancesOnconetix Highlights Realbotix's Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson
Vinci Enables Realbotix Robots to Recognize People, Recall Conversations, and Track Engagement; Onconetix Recently Entered into a Definitive Agreement to Acquire Realbotix LLC, a Subsidiary of Realbotix Corp.Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update
Realbotix Announces Expected Delivery of 19 Robots in March, April, and May 2026 as it Scales Production Capacity; Onconetix recently Entered into a Definitive Agreement to Acquire Realbotix LLC, a subsidiary of Realbotix Corp.Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors
Experienced Leadership Team Positioned to Execute Pending Transformative Acquisition of Realbotix LLC and Drive Long-Term Shareholder Value
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Onconetix
Onconetix is a biotechnology company focused on the research, development and commercialization of proprietary therapeutics, diagnostics and services in the field of oncology. The company provides innovative solutions for cancer treatment and diagnosis, offering specialized products and services designed for both healthcare providers and patients.... Read More